Cranberry capsules for the prevention of urinary tract infection in an elderly population

A randomised, double-blind, placebo-controlled crossover trial of cranberry capsules to prevent urinary tract infection in an elderly population

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12605000626662

Enrollment

120

Registered

2005-10-11

Start date

2005-11-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This project seeks to provide evidence for managing urinary tract infection (UTI) using cranberry for an elderly population. Such evidence is important because UTI causes pain and negatively impacts on the quality of life of elderly residents. While there is a growing literature on the use of cranberry for the prevention of UTI, this evidence needs to be further explored within an elderly population specifically. This study will determine if cranberry capsules have an effect on UTI incidence and which particular symptoms and characteristics of bacteriuria it has the greatest effect on.

Interventions

The cranberry trial is a randomised double-blind, placebo controlled crossover trial. The study is investigating the efficacy of cranberry capsules for the treatment of urinary tract infections in the elderly. In this trial, clients are randomised to take one capsule, once daily containing either cranberry or a placebo. The trial has a crossover design, with the placebo and intervention each being administered for 3 months duration.

Study design

Allocation

Randomised controlled trial

Intervention model

Crossover

Primary purpose

Prevention

Masking

Blinded (masking used)

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Outcome results